Technology
Health
Biotechnology

ASLAN Pharmaceuticals

$3.20
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.

-$0.02 (-0.62%) Today
$0.00 (0.00%) After Hours

Why Robinhood?

You can buy or sell ASLN and other stocks, options, ETFs, and crypto commission-free!

About

ASLAN Pharmaceuticals Limited American Depositary Shares, also called ASLAN Pharmaceuticals, is a clinical-stage oncology-focused biopharmaceutical company, which engages in the development of novel therapeutics. Its pipeline includes varlitinib, ASLAN003, ASLAN004, and ASLAN002. Read More The firm's portfolio focuses on validated growth pathways applied to new patient segments, novel immune checkpoints, and novel cancer metabolic pathways. The company was founded by Carl Aslan Jason Morton Firth, Mark McHale, and Jeffrey Tomlinson in 2010 and is headquartered in Singapore.

Employees
Headquarters
Singapore, Central Singapore
Founded
2010
Market Cap
102.48M
Price-Earnings Ratio
Dividend Yield
Average Volume
23.37K
High Today
$3.49
Low Today
$3.20
Open Price
$3.38
Volume
2.73K
52 Week High
$10.44
52 Week Low
$2.51

Collections

Technology
Health
Biotechnology
Medical
Biopharmaceutical
Therapy
Cancer Prevention
Pharmaceutical

Earnings

-$0.45
-$0.31
-$0.17
-$0.03
Q2 2018
Q3 2018
Q4 2018
Q1 2019
Q2 2019
Estimated
Actual
Expected Aug 5, Pre-Market
All investments involve risk and the past performance of a security, or financial product does not guarantee future results or returns. Securities offered through Robinhood Financial LLC, member FINRA/SIPC. To learn more about the information provided on this page, please see our Web Disclosures.